Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Lynparza approved in EU and Japan for BRCAm ovarian cancer

pharmaceutical-technologyJune 20, 2019

Tag: EU , Lynparza , BRCAm ovarian cancer

PharmaSources Customer Service